Search Results - "Al Fayez, Nojoud"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Recent Advancement in mRNA Vaccine Development and Applications by Al Fayez, Nojoud, Nassar, Majed S, Alshehri, Abdullah A, Alnefaie, Meshal K, Almughem, Fahad A, Alshehri, Bayan Y, Alawad, Abdullah O, Tawfik, Essam A

    Published in Pharmaceutics (01-07-2023)
    “…Messenger RNA (mRNA) vaccine development for preventive and therapeutic applications has evolved rapidly over the last decade. The mRVNA vaccine has proven…”
    Get full text
    Journal Article
  2. 2

    Chemically engineering the drug release rate of a PEG-paclitaxel conjugate using click and steric hindrance chemistries for optimal efficacy by Nguyen, Anne, Chao, Po-Han, Ong, Chun Yat, Rouhollahi, Elham, Fayez, Nojoud AL, Lin, Louis, Brown, Jennifer I., Böttger, Roland, Page, Brent, Wong, Harvey, Li, Shyh-Dar

    Published in Biomaterials (01-10-2022)
    “…A small molecule drug with poor aqueous solubility can be conjugated to a hydrophilic polymer like poly(ethylene glycol) (PEG) to form an amphiphilic…”
    Get full text
    Journal Article
  3. 3

    Lipid-based nanoparticle technologies for liver targeting by Böttger, Roland, Pauli, Griffin, Chao, Po-Han, AL Fayez, Nojoud, Hohenwarter, Lukas, Li, Shyh-Dar

    Published in Advanced drug delivery reviews (2020)
    “…Liver diseases such as hepatitis, cirrhosis, and hepatocellular carcinoma are global health problems accounting for approximately 800 million cases and over 2…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The mechanism of Hepatocyte-Targeting and safety profile of Phospholipid-Free small unilamellar vesicles by AL Fayez, Nojoud, Böttger, Roland, Brown, Jennifer, Rouhollahi, Elham, Li, Shyh-Dar

    Published in International journal of pharmaceutics (25-11-2022)
    “…[Display omitted] Phospholipid-free small unilamellar vesicles (PFSUVs) composed of cholesterol and TWEEN80 (5:1 mol ratio), with an average diameter of 60 nm,…”
    Get full text
    Journal Article
  6. 6

    Hepatocyte-targeted delivery of imiquimod reduces hepatitis B virus surface antigen by AL Fayez, Nojoud, Rouhollahi, Elham, Ong, Chun Yat, Wu, Jiamin, Nguyen, Anne, Böttger, Roland, Cullis, Pieter R., Witzigmann, Dominik, Li, Shyh-Dar

    Published in Journal of controlled release (01-10-2022)
    “…Hepatitis B virus (HBV) can rapidly replicate in the hepatocytes after transmission, leading to chronic hepatitis, liver cirrhosis and eventually…”
    Get full text
    Journal Article
  7. 7

    Improved Liver Delivery of Primaquine by Phospholipid-Free Small Unilamellar Vesicles with Reduced Hemolytic Toxicity by AL Fayez, Nojoud, Böttger, Roland, Rouhollahi, Elham, Cullis, Pieter R., Witzigmann, Dominik, Li, Shyh-Dar

    Published in Molecular pharmaceutics (06-06-2022)
    “…Hemolytic toxicity caused by primaquine (PQ) is a high-risk condition that hampers the wide use of PQ to treat liver-stage malaria. This study demonstrated…”
    Get full text
    Journal Article
  8. 8

    Development of a child-friendly oral drug formulation using liposomal multilamellar vesicle technology by AL Fayez, Nojoud, Böttger, Roland, Ghosh, Sreemoyee, Nakajima, Yushi, Chao, Po-Han, Rouhollahi, Elham, Nguyen, Anne, Cullis, Pieter R., Witzigmann, Dominik, Li, Shyh-Dar

    Published in International journal of pharmaceutics (25-09-2022)
    “…[Display omitted] Many medicines are only available in solid dosage forms suitable for adults, and extemporaneous compounding is required to prepare…”
    Get full text
    Journal Article
  9. 9
  10. 10